Esperion Therapeutics, Inc. (ESPR)
2.44
-0.03
(-1.21%)
USD |
NASDAQ |
Mar 13, 16:00
2.51
+0.07
(+2.87%)
After-Hours: 20:00
Esperion Therapeutics Total Liabilities (Quarterly) : 1.186B for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Nektar Therapeutics | 190.57M |
| Harrow, Inc. | 353.12M |
| Catalyst Pharmaceuticals, Inc. | 152.54M |
| Rigel Pharmaceuticals, Inc. | 169.14M |
| AnaptysBio, Inc. | 327.18M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 883.74M |
| Shareholders Equity (Quarterly) | -301.96M |
| Debt to Equity Ratio | -1.815 |
| Current Ratio | 1.538 |
| Net Debt Paydown Yield | 0.26% |